Fundraising upside CureDuchenne operates with a revenue range of 10M-25M and actively deploys donor proceeds into research and mission programs. This indicates potential for partnerships with fundraising platforms, annual giving programs, and donor management tools that optimize grant-making, event-based fundraising, and venture philanthropy approaches.

Strategic partnerships Recent collaborations with SonoThera and Tevard Biosciences, plus ongoing investments in biotech ventures, show a clear appetite for external R&D partnerships. This creates opportunities for sponsored research programs, clinical trial support services, and technology licensing or co-development deals.

Clinical leadership Appointment of a Vice President of Clinical and Medical Affairs and a focus on advancing Duchenne therapies signal a desire for enhanced clinical operations, regulatory strategy, and publishing capabilities. Solutions around clinical data management, trial operations, and investigator engagement could be attractive to CureDuchenne.

Global event platform Active events calendar including FUTURES National Conference and high-profile fundraising events demonstrates a ready-made channel for sponsor activation, experiential marketing, and VIP donor experiences. Sponsorship packages, event tech, and audience engagement services are potential fits.

Tech-enabled philanthropy The tech stack includes AWS, WordPress, Shopify, and analytics tooling, indicating comfort with digital platforms and data-driven fundraising. Opportunities exist to offer donor engagement platforms, analytics dashboards, CRM integrations, and digital fundraising optimization tools.